United States· US:0591-5713_40931661-1155-4850-baaa-227f066ed616
Amoxapine
A amoxapine product containing amoxapine, registered in United States by Actavis Pharma, Inc.. The same ATC class is registered in 4 of our 19 countries.
Checked against FDA National Drug Code directory (United States) on
Informational only — not a medical device.
Where it is registered
Amoxapine is registered in 4 of 19 countries.
Countries holding a registration under ATC N06AA17 (amoxapine), each read from that country’s own register.
- This record: United States, from FDA National Drug Code directory (United States)
- 2 of them publish a price we can compare per daily dose
Amoxapine · ATC N06AA17
4 / 19 countries
- Franceprice
- Japan
- United Kingdom
- United Statesprice
The record
At a glance
FDA National Drug Code directory (United States)- Active substance
- AMOXAPINE
- Manufacturer
- Actavis Pharma, Inc.
- Country
- United States (US)
- ATC code
- N06AA17
- ATC class
- Amoxapine
- Defined daily dose
- 0.15 g, O
- Reimbursed
- Not published by this register
- Source register
- FDA National Drug Code directory (United States)
- Last checked
- September 27, 2026
Packs & prices · 2
- ndc110591571301100 TABLET in 1 BOTTLE, PLASTIC (0591-5713-01)
- ndc110591-5713-01
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
305 interactions on record for amoxapine.
Graded by severity as the source publishes them — 65 severe. Severity grades are free for everyone; mechanism and management come with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Amoxapine · interactions on record
305 records
- 65 severe
- 223 moderate
- 16 minor
Most severe, free to view
- PapaverineA03AD01severe
- MetoclopramideA03FA01severe
- CisaprideA03FA02severe
- OndansetronA04AA01severe
1 more interaction with mechanism and management, from a commercially licensed source.
Sign in to check- Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Same medicine, other countries
Amoxapine in 2 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FDA National Drug Code directory (United States). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/6465740a-d5a1-4100-9e1a-770ce12ec322 GET /v1/drugs/6465740a-d5a1-4100-9e1a-770ce12ec322?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"route": "ORAL",
"source": "ndc",
"strength": "25",
"substance": "AMOXAPINE",
"productndc": "0591-5713",
"dosage_form": "TABLET",
"dea_schedule": null,
"strength_unit": "mg/1",
"application_number": "ANDA072691",
"marketing_category": "ANDA"
}See everything about amoxapine.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.